Health In Tech Stock Analysis
| HIT Stock | 1.80 -0.20 -10.00% |
Health In Tech is currently estimated as overvalued with a Real Value of $1.39. This stock analysis starts with the question of intrinsic value. The framework estimates Health In's value using fundamental inputs rather than market price alone. The framework combines financial statement analysis with technical price studies.
Health In Tech holds a debt-to-equity ratio of 1.14. The current value of Interest-Bearing Debt Per Share is estimated at 0.01, reflecting a contracting pattern. It was pegged at 0.01 in the prior reporting cycle. As of yesterday, Cash Flow To Debt Ratio is positioned to expand toward 9.95, while Short and Long Term Debt Total is moving lower toward slightly above 176.7 K. Higher debt levels can expand Health In's financial risk exposure. Interest payments can affect earnings and coverage ratios over time. Asset vs Debt
Equity vs Debt
Price Book 6.003 | Enterprise Value Ebitda 36.132 | Price Sales 3.3341 | Shares Float 11.5 M | Wall Street Target Price 4.5 |
Health In Tech's financial profile includes $670 thousand in Net Income, $1.2 million in Net Income From Continuing Ops, and $0.50 in Net Income Per EBT.
Refer to Gross Profit and Total Revenue for expanded analysis.
Stock Analysis Notes
About 75.0% of the company shares are held by company insiders. The company had its last dividend issued on the September 28, 2011. Health In Tech's financial profile includes $0.18 in Intangibles To Total Assets, $15.8 million in Total Assets, and a Return On Assets of 7.0%.Price To Sales Ratio | 29.57 |
Investor Insights and Alerts
| Health In Tech is way too risky over 90 days horizon | |
| Health In Tech may become a speculative penny stock | |
| Health In Tech appears to be risky and price may revert if volatility continues | |
| Health In Tech has a strong financial position based on the latest SEC filings | |
| About 75.0% of the company shares are held by company insiders | |
| Latest headline from benzinga.com: Health In Tech Surges Over 27 percent After Hours Heres Why |
Market Capitalization
Health In Tech is categorized as small-cap based on a market capitalization of 102.44 M relative to insurance brokers. Further market cap context comes from about 45.21 M shares outstanding, enterprise value near 95.14 M, and a workforce of about 73 people.Profitability
Profitability metrics test whether Health In Tech is building real earning power or just reporting one-time accounting gains. Current market capitalization is about 102.44 Million. Return on assets, return on equity, and cash flow deserve as much focus as earnings per share.
The company has Net Profit Margin of 5.0 %, which can signify that the company executes well on its competitive strategies and has good control over its expenditures. This is typical relative to the peer group. In the same way, it shows Net Operating Margin of 6.0 %, which suggests that the company runs its operations efficiently, retaining $6.0 per $100 of revenue. | Last Reported | End Of Year Estimate | ||
| Return On Tangible Assets | 0.05 | 0.10 | |
| Return On Capital Employed | 0.07 | 0.06 | |
| Return On Assets | 0.04 | 0.07 | |
| Return On Equity | 0.06 | 0.06 |
Management Efficiency
The company has Return on Asset of 5.33 % which means that it generated a profit of $5.33 on every $100 of assets employed. This is typical relative to the peer group. In the same way, it shows a return on shareholders' equity (ROE) of 11.94 %, which means that it returned $11.94 on every $100 dollars invested by stockholders.| Last Reported | End Of Year Estimate | ||
| Book Value Per Share | 0.18 | 0.19 | |
| Tangible Book Value Per Share | 0.12 | 0.13 | |
| Enterprise Value Over EBITDA | 210.11 | 199.61 | |
| Price Book Value Ratio | 31.38 | 29.81 | |
| Enterprise Value Multiple | 210.11 | 199.61 | |
| Price Fair Value | 31.38 | 29.81 | |
| Enterprise Value | 247.7 M | 219.9 M |
The management picture for Health In Tech becomes more useful when investors compare executive decisions with financial outcomes rather than with presentation language alone. The strongest reading comes from linking leadership decisions to return metrics, balance-sheet quality, and the durability of the business model.
Operating Margin | Short Long Term Debt | Operating Margin | Profit Margin | Short Long Term Debt Total |
Technical Drivers
As of the 23rd of March, shares of Health In change hands at 1.80 per share. Momentum and volatility readings indicate market risk adjusted performance of 3.39, and Risk Adjusted Performance of 0.1083. The system measures statistical relationships between price fluctuations and trading activity. Indicator values are assessed relative to historical performance bands.Health In Tech Price Movement Analysis
This analysis covers thirty-eight data points across the selected time horizon. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Health In middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Health In Tech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Insider Trading Activities
Insider activity around Health In Tech matters because officers and directors often act on business changes before the market catches up. The pattern is most useful when compared with earnings releases and guidance changes rather than treated alone.
Qian Linlin over two months ago Acquisition by Qian Linlin of 1000000 shares of Health In subject to Rule 16 b-3 | ||
Qian Linlin over two months ago Acquisition by Qian Linlin of 80000 shares of Health In subject to Rule 16 b-3 | ||
Zain Hasan over two months ago Insider Trading | ||
Clarkson Michael David over three months ago Acquisition by Clarkson Michael David of 8000 shares of Health In subject to Rule 16 b-3 | ||
Clarkson Michael David over three months ago Insider Trading | ||
Shrestha Sanjay K over three months ago Acquisition by Shrestha Sanjay K of 5730 shares of Health In at 3.49 subject to Rule 16 b-3 | ||
Shrestha Sanjay K over three months ago Disposition of 65469 shares by Shrestha Sanjay K of Health In subject to Rule 16 b-3 | ||
Qian Linlin over three months ago Acquisition by Qian Linlin of 80000 shares of Health In subject to Rule 16 b-3 | ||
Umemezia Chike over six months ago Acquisition by Umemezia Chike of 128474 shares of Health In at 0.62 subject to Rule 16 b-3 |
Outstanding Bonds
Outstanding bonds linked to Health In Tech can tell investors a great deal about how the company finances itself beyond common equity markets. Maturity profile, refinancing windows, and coupon burden can all affect how resilient the capital structure looks in a weaker market.
| HEALTH CARE REIT Corp BondUS42217KAX46 | View | |
| HEALTH CARE REIT Corp BondUS42217KBB17 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| US42218SAF56 Corp BondUS42218SAF56 | View | |
| US42218SAH13 Corp BondUS42218SAH13 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Predictive Daily Indicators
Daily signals in Health In Tech help active traders track momentum, reversals, and volume pressure during the session. Used carefully, they can improve execution without tempting investors to overtrade every small swing.
Forecast Models
Quantitative tools for Health In Tech focus on observed patterns, which helps when markets move faster than research can update. These models describe patterns, not guarantees. The real test is whether market conditions have changed enough to break the old pattern.Financial Strength and Earnings Quality Indicators
Health In Tech financial ratings play a critical role in determining how much Health In have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Health In's borrowing costs.| Piotroski F Score | 8 | Strong | View |
| Beneish M Score | -2.77 | Unlikely Manipulator | View |
Debt to Cash Allocation
Health In Tech has $206.69 K in debt with debt to equity (D/E) ratio of 1.14, which is consistent with its industry peers. Health In Tech has a current ratio of 1.15, demonstrating that it is not liquid enough and may have problems paying out its financial commitments when the payables are due. Note however, debt can serve as one financing mechanism for Health, though the impact on returns depends on execution and market conditions.Total Assets Over Time
Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Health In uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Health In Debt Ratio | 1.12 |
Corporate Bonds Issued
Health Short Long Term Debt Total
Short Long Term Debt Total | 176,722 |
Stock Analysis Methodology
The diagnostic for Health In shows how profitability, leverage, and market risk compare. Health In trades at P/E of 24.13, P/B of 6.0, P/S of 3.33. Profitability metrics show ROE of 11.94%, net margin of 4.68%, operating margin of 5.81%. Balance sheet indicators include debt-to-equity of 1.14 and current ratio of 1.17. Financial distress probability is estimated at 3%, indicating low near-term solvency risk. RSI at 56 is in neutral territory. A beta of 0.2269 indicates low sensitivity to broad market moves. Sharpe ratio of 0.0844 reflects the risk-adjusted return profile.
Inputs for Health In Tech come from periodic company reporting and market reference feeds and are mapped into a consistent schema for analysis. Some fields can appear with publication lag.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardBe your own money manager
Wealth building around Health In Tech is more effective when position sizing, diversification, and expected return are reviewed together rather than as separate decisions. A disciplined process can make capital allocation more consistent and less reactive.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Additional Tools for Health Stock Analysis
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |